What metrics would you use to evaluate Cue Health's Cue Reader device?

Introduction

Evaluating the success of Cue Health's Cue Reader device requires a comprehensive approach to product metrics. This at-home diagnostic device represents a significant innovation in healthcare technology, and its performance metrics must reflect its impact on both individual users and the broader healthcare ecosystem. I'll follow a structured framework that covers core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

The Cue Reader is a portable, connected diagnostic device that allows users to perform lab-quality molecular tests at home. It works in conjunction with single-use test cartridges to detect various health conditions, including COVID-19, influenza, and other respiratory infections.

Key stakeholders include:

• End users (patients/consumers)
• Healthcare providers
• Insurance companies
• Regulatory bodies (e.g., FDA)
• Cue Health (the company)

User flow:

1. User inserts a test cartridge into the Cue Reader
2. User collects a sample (e.g., nasal swab) and inserts it into the cartridge
3. The device processes the sample and sends results to the user's smartphone app
4. Results can be shared with healthcare providers or relevant authorities

The Cue Reader fits into Cue Health's broader strategy of democratizing access to accurate, rapid diagnostics. It competes with traditional lab-based testing and other at-home testing solutions, offering faster results and higher accuracy than many alternatives.

Product Lifecycle Stage: The Cue Reader is in the growth stage, having gained significant traction during the COVID-19 pandemic but still expanding its use cases and market penetration.

Hardware-specific considerations:

• Manufacturing scalability and quality control
• Supply chain management for device components and test cartridges
• Maintenance and support infrastructure for deployed devices